The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
about
Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunityC-terminus of OX2R significantly affects downstream signaling pathwaysDiscovery of dual-action membrane-anchored modulators of incretin receptorsMechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblastsIrinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways.Illuminating the life of GPCRsMapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptorThe C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation.Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.
P2860
Q27015870-2254B744-0620-4E8F-8BFB-FB64CE9DB9E4Q33828163-6A495E0D-68F0-463C-ADA6-51DCF6A1572FQ35213989-88054592-B738-422F-8450-AB9F60D37B81Q36063090-D91AB6C7-B81D-4D92-A3B1-B0B7BA2B87E0Q36171894-495F4541-0197-4039-B3A2-61C70BD2D174Q36638807-92CABFD9-698F-4757-A750-A0CE3303DA29Q36667043-E91E9EA3-4CA7-4E6B-9412-0FD7B3F970F5Q37551248-1A69975E-7ED3-4ED1-8350-466C049F7553Q39411727-D98A7DF9-A2C6-4F13-8A35-DF92195F6700Q39916587-4CF08959-E249-4D4A-8E9A-FB9857EC1FA9Q39929423-853539E7-C0F8-4472-A17E-A401E77CF125
P2860
The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The glucagon-like peptide-2 re ...... dependent effector activation.
@ast
The glucagon-like peptide-2 re ...... dependent effector activation.
@en
The glucagon-like peptide-2 re ...... dependent effector activation.
@nl
type
label
The glucagon-like peptide-2 re ...... dependent effector activation.
@ast
The glucagon-like peptide-2 re ...... dependent effector activation.
@en
The glucagon-like peptide-2 re ...... dependent effector activation.
@nl
prefLabel
The glucagon-like peptide-2 re ...... dependent effector activation.
@ast
The glucagon-like peptide-2 re ...... dependent effector activation.
@en
The glucagon-like peptide-2 re ...... dependent effector activation.
@nl
P2860
P356
P1476
The glucagon-like peptide-2 re ...... -dependent effector activation
@en
P2093
Bernardo Yusta
Jacqueline A Koehler
P2860
P304
22124-22134
P356
10.1074/JBC.M500078200
P407
P577
2005-04-06T00:00:00Z